Contributor Page
Hogan Lovells
 
Email  |  Articles
Contact Details
Tel: +32 2 505 0911
Fax: +32 2 505 0996
Pericles Building
Rue de la Science 23
Brussels
1040
Belgium
Awards
Contributor Most Read
Most Reader Response
Most Reader Response
Most Reader Response
Most Reader Response
Most Reader Response
Most Reader Response
By Ronald L. Wisor, Jr., Melissa K. Bianchi, Helen R. Trilling, Stuart M. Langbein, Jonathan L. Diesenhaus, Elizabeth (Beth) Halpern, Thomas Beimers, Eliza L. Andonova, Andrew S. Furlow
In a significant step towards implementing its American Patients First blueprint for lowering prescription drug prices and patient out-of-pocket costs
By Mandi Krebs, Vaughn Harrison
Following the recent landmark decision of the South African Constitutional Court, in which the private and personal use of cannabis was decriminalised, together with the publication of guidelines regarding the...
By Craig H. Smith, Brooke Bumpers
From mobile apps for monitoring medications to virtual appointments with specialists, telehealth services are creating new levels of convenience for providers and patients.
By Thomas Beimers, Andrew S. Furlow
Investing in the life sciences industry without an understanding of the key regulatory factors that could determine a product's success or failure could cost you millions of dollars.
By Martin J. Hahn, Lynn Mehler, Sam Dietle, Delia Deschaine
On December 20, 2018, President Donald Trump signed the Agricultural Improvement Act of 2018 (the 2018 Farm Bill) into law.
By Alice Valder Curran, Ken Choe, Christopher H. Schott, Kathleen A. Peterson, Margaux J. Hall, Samantha D. Marshall
Yesterday, the HRSA issued a Final Rule that accelerates the effective and implementation date of the 340B Ceiling Price and Civil Monetary Penalties final rule from July 1, 2019, to January 1, 2019.
By Alice Valder Curran, Christopher H. Schott, Elizabeth (Beth) Halpern, Margaux J. Hall
Investing in the life sciences industry without an understanding of the key regulatory factors that could determine a product's success or failure could cost you millions of dollars.
By Susan Lee, Yarmela Pavlovic
On 20 November the Food and Drug Administration (FDA) published a request for comments
By Christian Herweg, Falk Loose, Jan Fürbaß
Recently the German legislature passed a new law, exempting extraordinary profits created by the waiver of claims under restructurings from income tax liability.
By Romain de Ménonville, Pierre Jean Martinez Chénard
The Recast Insolvency Regulation 2015/848 governs cross-border insolvency proceedings within the European Union
By Anthony Woolley, Aston Goad, Indra Dwisatria
As part of its 16th economic package, the Government of Indonesia (GOI) announced on 16 November 2018 that in order to attract further foreign investment ...
By Norm Coleman, Robert Kyle, Ivan Zapien, Kate McAuliffe
The dust has settled. In the next Congress beginning early 2019, Democrats will take control of the House, and Republicans have expanded their majority in the Senate.
By Christine Borries (née Ede), Maximilian Baier
The recently published report on the evaluation of the ESUG, the German law to facilitate the restructuring of companies, states that the changes introduced by the ESUG have been received...
By Alice Valder Curran, Beth L. Roberts, Elizabeth (Beth) Halpern, Stuart M. Langbein, Ken Choe, Christopher H. Schott, Kathleen A. Peterson, Ali Lakhani, Samantha D. Marshall, Margaux J. Hall
On October 25, 2018, the Centers for Medicare & Medicaid Services (CMS) issued an advance notice of proposed rulemaking (ANPRM) ...
By Alice Valder Curran, Ken Choe, Christopher H. Schott, Kathleen A. Peterson, Margaux J. Hall, Samantha D. Marshall
Yesterday, the HRSA issued a Proposed Rule to cease any further delay of the 340B Ceiling Price and Civil Monetary Penalties regulation and change its effective date and implementation date from July 1, 2019, to January 1, 2019.